Streetbeat News

Regulatory

CSCO

SPLK

Splunk Inc. has announced the expiration of the Hart-Scott-Rodino waiting period for its acquisition by Cisco for $157 per share in cash. The merger is still subject to other closing conditions, including antitrust and foreign investment law approvals and Splunk stockholder approval. The expected completion is by the end of Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:24 pm

RDHL

RedHill Biopharma Ltd. (RDHL) has been approved to transfer its listing from the Nasdaq Global Market to the Nasdaq Capital Market due to non-compliance with the minimum Market Value of Publicly Held Shares requirement. The transfer will occur on November 15, 2023, without affecting trading under the ticker RDHL. The company also faces a compliance issue with the minimum bid price requirement and has until March 18, 2024, to meet this standard or potentially receive an additional compliance period.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:12 pm

MLTX

MoonLake, with $496M in cash, cash equivalents, and short-term marketable securities, is well-capitalized to fund its Phase 3 programs for Hidradenitis Suppurativa and Psoriatic Arthritis, including regulatory submissions and additional research.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:12 pm

A

MRK

Agilent Technologies received FDA approval for its PD-L1 IHC 22C3 PharmDx as a diagnostic tool for identifying patients with gastric or gastroesophageal junction adenocarcinoma who may benefit from Merck's Keytruda treatment.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 1:06 pm

NTLA

Intellia Therapeutics has received Orphan Drug Designation from the European Commission for NTLA-2002, a treatment for Hereditary Angioedema. This designation could provide certain benefits, including market exclusivity, assistance with clinical development, and reduced regulatory fees.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:32 pm

BTAI

BioXcel Therapeutics has agreed to follow FDA recommendations for a Phase 3 trial of its TRANQUILITY program, which aims to support a potential supplemental New Drug Application (sNDA) for the acute treatment of agitation in patients with dementia related to Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:06 pm

WKHS

Workhorse Group Inc. reported that their financial results for Q3 and the yearly outlook were significantly affected by delays in the Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project (HVIP) vouchers.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:03 pm

NOTE

FiscalNote, a technology provider of global policy and market intelligence, has filed with the SEC for a mixed shelf offering allowing the company to issue various types of securities up to $100 million. This move could potentially dilute current shareholders but also provides the company with flexible financing options for future growth, acquisitions, debt management, or other corporate expenses.

Portfolio Pulse from Charles Gross

November 14, 2023 | 11:44 am

BLK

WETF

Anticipation grows as the U.S. SEC nears the approval of the first spot Bitcoin ETF, with firms like BlackRock, WisdomTree, and Valkyrie in line. Bitcoin's price surged following BlackRock's move towards an Ethereum ETF. Experts predict a potential bitcoin rally post-approval but caution about possible price dips from profit-taking. Financial advisors show increased interest in crypto with 72% more likely to invest if spot ETFs are available.

Portfolio Pulse from Benzinga Neuro

November 14, 2023 | 10:54 am

SOL

Mad Lads NFTs on the Solana blockchain have hit a new all-time high in price following the appointment of Can Sun, a former FTX general counsel, to lead Trek Labs, a startup associated with Backpack and Coral. Trek Labs, which has secured a Virtual Asset Service Provider license in Dubai, is offering a 10% stake in the company, valued at over $100 million. The beta signups for the Backpack exchange are currently open exclusively to Mad Lads NFT holders, potentially driving up demand for these NFTs.

Portfolio Pulse from Benzinga Neuro

November 14, 2023 | 10:50 am